Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Luigi Scarpato
Frequency of Circulating CD8+CD73+T Cells Is Associated With Survival in Nivolumab-Treated Melanoma Patients
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Presence of Circulating Her2-Reactive CD8 + T-Cells Is Associated With Lower Frequencies of Myeloid-Derived Suppressor Cells and Regulatory T Cells, and Better Survival in Older Breast Cancer Patients
Breast Cancer Research
Cancer Research
Oncology
Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
JAMA Oncology
Cancer Research
Oncology
Circulating CD56bright NK Cells Inversely Correlate With Survival of Melanoma Patients
Scientific Reports
Multidisciplinary
P2.04-02 Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated With Nivolumab
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Dramatic Survival Benefit With Nivolumab in Melanoma
Cancer Discovery
Oncology
Presence of Suppressor HIV-Specific CD8+ T Cells Is Associated With Increased PD-1 Expression on Effector CD8+ T Cells
Journal of Immunology
Allergy
Immunology
Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
High Frequency of T Cells Specific for Cryptic Epitopes in Melanoma Patients
OncoImmunology
Oncology
Allergy
Immunology
Detection of Circulating Melanoma Cells in the Blood of Melanoma Patients
Melanoma Research
Dermatology
Cancer Research
Oncology
